Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Organ Protection in Cardiac Surgery
NCT02786212Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Sep 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in reperfusion injury (IRI) and acute kidney injury (AKI), sponsored by National Taiwan University Hospital. Primary endpoints: Perfused Vessel Density and Serum Diamine Oxidase Activity. Started Sep 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
reperfusion injury (IRI)acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02786212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02786212.